Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
82.41
+1.17 (1.44%)
At close: May 29, 2025, 4:00 PM
82.43
+0.02 (0.02%)
After-hours: May 29, 2025, 7:57 PM EDT
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | 12.48B | 12.28B | 12.17B | 11.99B | 11.83B | 11.47B | 11.32B | 11.11B | - | |||||||||
| Cardiovascular Growth | 5.49% | 6.99% | 7.51% | 7.93% | 5.46% | 2.52% | 0.64% | -2.76% | - | |||||||||
| Neuroscience | 9.85B | 9.77B | 9.67B | 9.51B | 9.41B | 9.11B | 8.94B | 8.77B | - | |||||||||
| Neuroscience Growth | 4.67% | 7.26% | 8.13% | 8.41% | 6.32% | 4.19% | 2.84% | -0.17% | - | |||||||||
| Medical Surgery | 8.41B | 8.39B | 8.47B | 8.48B | 8.53B | 8.47B | 8.39B | 8.25B | - | |||||||||
| Medical Surgery Growth | -1.40% | -0.85% | 0.98% | 2.87% | 1.04% | -1.47% | -4.91% | -9.79% | - | |||||||||
| Diabetes | 2.76B | 2.69B | 2.63B | 2.56B | 2.49B | 2.40B | 2.31B | 2.25B | - | |||||||||
| Diabetes Growth | 10.73% | 12.05% | 13.79% | 13.90% | 9.89% | 5.27% | 0.30% | -3.98% | - |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | Apr 24, 2020 | Jan 24, 2020 | Oct 25, 2019 | Jul 26, 2019 | Apr 26, 2019 | Jan 25, 2019 | Oct 26, 2018 | Jul 27, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| US | 17.17B | 16.97B | 16.85B | 16.72B | 16.56B | 16.70B | 16.64B | 16.53B | ||||||||||||||||||||
| US Growth | 3.67% | 1.62% | 1.27% | 1.14% | 1.15% | 4.38% | 4.83% | 4.63% | ||||||||||||||||||||
| Rest of World | 16.37B | 16.23B | 16.15B | 15.86B | 15.80B | 15.62B | 15.32B | 15.03B | ||||||||||||||||||||
| Rest of World Growth | 3.58% | 3.90% | 5.40% | 5.52% | 6.38% | 5.72% | 2.56% | -1.60% |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative | 10.85B | 10.89B | 10.85B | 10.78B | 10.74B | 10.59B | 10.53B | 10.46B |
| Selling, General, and Administrative Growth | 1.05% | 2.89% | 3.04% | 3.04% | 3.09% | 2.12% | 2.09% | 1.44% |
| Research and Development | 2.73B | 2.72B | 2.74B | 2.74B | 2.74B | 2.70B | 2.69B | 2.67B |
| Research and Development Growth | -0.15% | 0.81% | 1.82% | 2.69% | 1.48% | -0.26% | 0.22% | -0.60% |
| Amortization | 1.81B | 1.66B | 1.67B | 1.68B | 1.69B | 1.70B | 1.71B | 1.70B |
| Amortization Growth | 6.80% | -2.00% | -2.52% | -1.58% | -0.35% | -0.82% | -0.18% | -0.99% |
| Litigation | 317.00M | 147.00M | - | 190.00M | 149.00M | - | 75.00M | 10.00M |
| Litigation Growth | 112.75% | - | - | 1,800.00% | - | - | - | - |
| Restructuring | 267.00M | 232.00M | 209.00M | 219.00M | 226.00M | 408.00M | 426.00M | 416.00M |
| Restructuring Growth | 18.14% | -43.14% | -50.94% | -47.36% | -39.89% | 270.91% | 407.14% | 550.00% |
| Other Expenses | -23.00M | 439.00M | 461.00M | 464.00M | 464.00M | 43.00M | -99.00M | -165.00M |
| Other Expenses Growth | - | 920.93% | - | - | - | - | - | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.